Green Planet Bio Engineering (GPLB) Common Equity (2016 - 2026)
Green Planet Bio Engineering's Common Equity history spans 16 years, with the latest figure at -$511920.0 for Q1 2026.
- On a quarterly basis, Common Equity fell 8.46% to -$511920.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$511920.0, a 8.46% decrease, with the full-year FY2025 number at -$500976.0, down 7.71% from a year prior.
- Common Equity came in at -$511920.0 for Q1 2026, down from -$500976.0 in the prior quarter.
- The five-year high for Common Equity was -$363045.0 in Q1 2022, with the low at -$511920.0 in Q1 2026.
- Historically, Common Equity has averaged -$434558.6 across 5 years, with a median of -$436055.0 in 2024.
- Biggest five-year swings in Common Equity: decreased 12.48% in 2023 and later fell 6.52% in 2025.
- Year by year, Common Equity stood at -$381920.0 in 2022, then fell by 12.48% to -$429590.0 in 2023, then dropped by 8.27% to -$465134.0 in 2024, then decreased by 7.71% to -$500976.0 in 2025, then fell by 2.18% to -$511920.0 in 2026.
- Business Quant data shows Common Equity for GPLB at -$511920.0 in Q1 2026, -$500976.0 in Q4 2025, and -$484678.0 in Q3 2025.